Table 3.
Comparative analysis of clinicopathological data of exposed and unexposed breast cancer patients from intermediate-risk stratification.
| Variable | Group | Category | % | p Value |
|---|---|---|---|---|
| Estrogen receptor | Exposed | Negative | 7.79 | >0.05 |
| Positive | 92.21 | |||
| Unexposed | Negative | 5.88 | ||
| Positive | 94.11 | |||
| Progesterone receptor | Exposed | Negative | 44.16 | >0.05 |
| Positive | 55.84 | |||
| Unexposed | Negative | 45.09 | ||
| Positive | 54.9 | |||
| KI67 (%) | Exposed | <14 | 41.09 | >0.05 |
| >14 | 58.9 | |||
| Unexposed | <14 | 45.83 | ||
| >14 | 54.16 | |||
| Molecular subtype | Exposed | Luminal A | 38.96 | >0.05 |
| Luminal B | 57.14 | |||
| Triple negative | 3.9 | |||
| Unexposed | Luminal A | 43.13 | ||
| Luminal B | 47.05 | |||
| Triple negative | 9.8 | |||
| Tumor size (cm) | Exposed | <2 | 35.61 | >0.05 |
| >2 | 64.38 | |||
| Unexposed | <2 | 40 | ||
| >2 | 60 | |||
| Histological grade | Exposed | I and II | 81.33 | >0.05 |
| III | 18.66 | |||
| Unexposed | I and II | 80.39 | ||
| III | 19.6 | |||
| Lymphnodal metastases | Exposed | None affected | 60 | 0.0353 * |
| At least one affected | 40 | |||
| Unexposed | None affected | 74 | ||
| At least one affected | 26 | |||
| Age at diagnosis | Exposed | <50 | 32.47 | >0.05 |
| >50 | 67.53 | |||
| Unexposed | <50 | 39.21 | ||
| >50 | 60.78 | |||
| Menopause status at diagnosis | Exposed | No | 27.27 | >0.05 |
| Yes | 72.73 | |||
| Unexposed | No | 35.29 | ||
| Yes | 64.7 | |||
| BMI | Exposed | Eutrophic | 25 | 0.0478 * |
| Overweight/obese | 75 | |||
| Unexposed | Eutrophic | 38 | ||
| Overweight/obese | 62 |
* p < 0.05. Chi-square analysis.